ALEXANDRA BALCOM: Open Payments
NPI 1376373811 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 24 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $250 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $162 |
| Lilly USA, LLC | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Novo Nordisk Inc | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Smith+Nephew, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: REPATHA, AIRSUPRA, INGREZZA, OTEZLA, JARDIANCE, MOUNJARO, FREESTYLE LIBRE 2, XIFAXAN.
Industry payments across FL — which companies pay providers there.
